Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

Thermo Fisher Scientific Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Mar 28, 2026 = ×
Dec 31, 2025 = ×
Sep 27, 2025 = ×
Jun 28, 2025 = ×
Mar 29, 2025 = ×
Dec 31, 2024 = ×
Sep 28, 2024 = ×
Jun 29, 2024 = ×
Mar 30, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jul 1, 2023 = ×
Apr 1, 2023 = ×
Dec 31, 2022 = ×
Oct 1, 2022 = ×
Jul 2, 2022 = ×
Apr 2, 2022 = ×

Based on: 10-Q (reporting date: 2026-03-28), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-27), 10-Q (reporting date: 2025-06-28), 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02).


The Return on Equity (ROE) exhibited a significant downward trend during the initial phase of the observed period, declining from a peak of 18.56% in April 2022 to a low of 12.52% by September 2024. Following this contraction, the ROE entered a period of relative stabilization, fluctuating within a narrow range between 12.55% and 13.19% through March 2026.

Return on Assets (ROA)
A consistent decline in asset efficiency is observed from April 2022 (8.20%) through July 2023 (6.08%). This reduction represents the primary driver of the overall decrease in shareholder returns. From mid-2023 through the conclusion of the period, ROA remained largely stagnant, oscillating between 6.05% and 6.58%, indicating a plateau in the ability to generate earnings from the asset base.
Financial Leverage
The financial leverage ratio followed a gradual downward trajectory, starting at 2.26 in April 2022 and reaching a minimum of 1.96 in December 2024. This trend indicates a reduction in the use of debt to finance assets, which diminished the multiplier effect on equity returns. A modest recovery in leverage is noted toward the end of the period, rising to 2.18 by March 2026.
Two-Component Interaction
The compression of ROE was the result of a simultaneous decline in both operating efficiency (ROA) and financial gearing (leverage). While the drop in ROA provided the most substantial negative impact, the reduction in the leverage ratio further accelerated the decline in ROE. In the final quarters of the analysis, the stabilization of ROE was supported by a marginal increase in financial leverage, which effectively offset the lack of significant growth in ROA.

Three-Component Disaggregation of ROE

Thermo Fisher Scientific Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Mar 28, 2026 = × ×
Dec 31, 2025 = × ×
Sep 27, 2025 = × ×
Jun 28, 2025 = × ×
Mar 29, 2025 = × ×
Dec 31, 2024 = × ×
Sep 28, 2024 = × ×
Jun 29, 2024 = × ×
Mar 30, 2024 = × ×
Dec 31, 2023 = × ×
Sep 30, 2023 = × ×
Jul 1, 2023 = × ×
Apr 1, 2023 = × ×
Dec 31, 2022 = × ×
Oct 1, 2022 = × ×
Jul 2, 2022 = × ×
Apr 2, 2022 = × ×

Based on: 10-Q (reporting date: 2026-03-28), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-27), 10-Q (reporting date: 2025-06-28), 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02).


The Return on Equity (ROE) exhibits a general downward trajectory over the analyzed period, starting at 18.56% in April 2022 and stabilizing at 13.19% by March 2026. The most significant decline occurred between April 2022 and July 2023, after which the ROE entered a period of relative stagnation with minor fluctuations between 12.5% and 13.2%.

Net Profit Margin
The profit margin serves as the primary driver of ROE volatility. A marked contraction is observed from a peak of 18.49% in April 2022 to a low of 13.14% in July 2023. Following this decline, the margin demonstrated a gradual recovery and stabilization, trending upward to 15.15% by March 2026. This recovery suggests a successful effort to stabilize operational efficiency or pricing power after a period of margin compression.
Asset Turnover
Asset utilization remained relatively stable but showed a subtle long-term erosion. After peaking at 0.49 in October 2022, the ratio entered a slow decline, reaching 0.40 by the end of the period in March 2026. This suggests a slight decrease in the efficiency with which assets are being utilized to generate revenue.
Financial Leverage
The financial leverage ratio fluctuated within a range of 1.96 to 2.26. There was a general trend toward deleveraging from April 2022 (2.26) to a trough in December 2024 (1.96). However, a reversal in this trend is evident in the final three quarters, with leverage increasing to 2.18 by March 2026. The lack of aggressive leveraging during the margin slump indicates a conservative approach to capital structure management.

The overall decline in ROE is predominantly attributable to the compression of the net profit margin during 2022 and 2023, further compounded by a marginal decrease in asset turnover. While the recovery in profit margins and a recent increase in financial leverage have provided some support to ROE in the most recent quarters, they have not yet returned the equity return to its 2022 levels.


Five-Component Disaggregation of ROE

Thermo Fisher Scientific Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Mar 28, 2026 = × × × ×
Dec 31, 2025 = × × × ×
Sep 27, 2025 = × × × ×
Jun 28, 2025 = × × × ×
Mar 29, 2025 = × × × ×
Dec 31, 2024 = × × × ×
Sep 28, 2024 = × × × ×
Jun 29, 2024 = × × × ×
Mar 30, 2024 = × × × ×
Dec 31, 2023 = × × × ×
Sep 30, 2023 = × × × ×
Jul 1, 2023 = × × × ×
Apr 1, 2023 = × × × ×
Dec 31, 2022 = × × × ×
Oct 1, 2022 = × × × ×
Jul 2, 2022 = × × × ×
Apr 2, 2022 = × × × ×

Based on: 10-Q (reporting date: 2026-03-28), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-27), 10-Q (reporting date: 2025-06-28), 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02).


The Return on Equity (ROE) experienced a significant downward trend during the first half of the analyzed period, declining from a peak of 18.56% in April 2022 to a low of 12.52% by September 2024. Following this contraction, the ROE entered a period of stabilization, oscillating between 12.55% and 13.19% through March 2026. This decline in equity returns is the result of multiple converging factors across operational efficiency, financial costs, and capital structure.

Operating Profitability and Efficiency
The EBIT Margin exhibited a pronounced "V-shaped" pattern. It began at 22.24% in April 2022, bottomed out at 16.29% in July 2023, and subsequently recovered to stabilize around 19.4% to 19.6% from June 2024 onward. While the margin recovered from its trough, it did not return to the initial 2022 levels, contributing to the overall lower ROE. Concurrently, Asset Turnover showed a gradual deterioration, shifting from a peak of 0.49 in October 2022 to 0.40 by December 2025, indicating a slight reduction in the efficiency of asset utilization to generate revenue.
Financial and Tax Burdens
A notable decline is observed in the Interest Burden, which fell from 0.94 in early 2022 to a low of 0.82 by March 2024, before leveling off around 0.83. This trend suggests an increase in interest expenses relative to operating income, which acted as a persistent drag on net profitability. In contrast, the Tax Burden remained relatively stable, fluctuating within a narrow range between 0.88 and 0.95, indicating that tax efficiency was not a primary driver of the ROE volatility.
Financial Leverage
Financial Leverage followed a general downward trajectory for the majority of the period, moving from 2.26 in April 2022 to a low of 1.96 by December 2024. The reduction in the equity multiplier diminished the magnifying effect of profitability on ROE. However, a reversal is noted toward the end of the period, with leverage climbing back to 2.18 by March 2026, which supported the stabilization of ROE despite the lower asset turnover.

In summary, the compression of ROE was primarily driven by a sharp mid-period decline in EBIT margins and a sustained increase in the interest burden. Although operating margins recovered and financial leverage increased toward the end of the sequence, these improvements were partially offset by a long-term decline in asset turnover, preventing the ROE from returning to its 2022 levels.


Two-Component Disaggregation of ROA

Thermo Fisher Scientific Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Mar 28, 2026 = ×
Dec 31, 2025 = ×
Sep 27, 2025 = ×
Jun 28, 2025 = ×
Mar 29, 2025 = ×
Dec 31, 2024 = ×
Sep 28, 2024 = ×
Jun 29, 2024 = ×
Mar 30, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jul 1, 2023 = ×
Apr 1, 2023 = ×
Dec 31, 2022 = ×
Oct 1, 2022 = ×
Jul 2, 2022 = ×
Apr 2, 2022 = ×

Based on: 10-Q (reporting date: 2026-03-28), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-27), 10-Q (reporting date: 2025-06-28), 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02).


The Return on Assets (ROA) exhibits a general downward trajectory over the analyzed period, characterized by an initial sharp decline followed by a period of relative stability and a final slight deterioration. This performance is the result of divergent trends between profitability margins and asset utilization efficiency.

Net Profit Margin
A significant contraction in profitability is observed during the first half of the sequence, with the margin falling from a peak of 18.49% in April 2022 to a trough of 13.14% by July 2023. Following this decline, the margin entered a recovery phase, stabilizing between 14.20% and 15.23% from March 2024 through March 2026. This suggests a successful stabilization of operational costs or pricing strategies after a period of margin compression.
Asset Turnover
Asset utilization shows a gradual and consistent long-term decline. After reaching a peak ratio of 0.49 in October 2022, the turnover ratio steadily eroded, ending at 0.40 in March 2026. This downward trend indicates that the company is generating progressively less revenue per unit of asset, suggesting either an increase in the asset base that has not yet yielded proportional revenue growth or a slowing of sales volume relative to capital investment.
ROA Disaggregation and Interaction
The volatility in ROA is primarily attributed to the net profit margin in the early stages of the period. Between April 2022 and July 2023, the decline in ROA from 8.20% to 6.08% was driven almost exclusively by the collapse in profit margins, as asset turnover remained relatively stable. In the subsequent period, from December 2023 to March 2025, ROA experienced a modest recovery to 6.58%, supported by the improving net profit margin despite the continuing decline in asset turnover. However, in the final phases of the analysis, the sustained decrease in asset turnover became the dominant driver, pulling ROA back down to 6.05% by March 2026, even while profit margins remained stable.

Four-Component Disaggregation of ROA

Thermo Fisher Scientific Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Mar 28, 2026 = × × ×
Dec 31, 2025 = × × ×
Sep 27, 2025 = × × ×
Jun 28, 2025 = × × ×
Mar 29, 2025 = × × ×
Dec 31, 2024 = × × ×
Sep 28, 2024 = × × ×
Jun 29, 2024 = × × ×
Mar 30, 2024 = × × ×
Dec 31, 2023 = × × ×
Sep 30, 2023 = × × ×
Jul 1, 2023 = × × ×
Apr 1, 2023 = × × ×
Dec 31, 2022 = × × ×
Oct 1, 2022 = × × ×
Jul 2, 2022 = × × ×
Apr 2, 2022 = × × ×

Based on: 10-Q (reporting date: 2026-03-28), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-27), 10-Q (reporting date: 2025-06-28), 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02).


The Return on Assets (ROA) exhibited a general downward trajectory from a peak of 8.21% in July 2022 to a stabilized range between 6.05% and 6.58% from 2024 through early 2026. This decline was primarily driven by a contraction in operational margins and an increased interest burden during the first half of the observed period, with a subsequent period of relative stability.

EBIT Margin
A significant volatility pattern is observed in operational profitability. The margin declined from 22.24% in April 2022 to a trough of 16.29% in July 2023. Following this decline, a recovery phase occurred, with the margin stabilizing between 19.38% and 19.56% from December 2023 through March 2026. This recovery suggests a successful correction of operational efficiencies or a stabilization of cost structures.
Interest Burden
There is a clear downward trend in the interest burden ratio, moving from 0.94 in early 2022 to a low of 0.82 by March 2024. This decrease indicates that a larger proportion of operating income was consumed by interest expenses during this timeframe. The ratio remained relatively flat between 0.82 and 0.84 throughout the remainder of the period, suggesting that the cost of debt became a consistent drag on net income.
Asset Turnover
Asset utilization shows a gradual decline over the analyzed period. After peaking at 0.49 in October 2022, the turnover ratio drifted lower, eventually reaching 0.40 by March 2026. This downward trend indicates a decrease in the efficiency of generating revenue from the asset base, which contributed to the overall reduction in ROA despite the recovery in EBIT margins.
Tax Burden
The tax burden remained the most stable component of the ROA disaggregation. The ratio fluctuated within a narrow band, starting at 0.88 and peaking at 0.95 in 2023, before settling around 0.92 to 0.93 in the final quarters. The minimal variance suggests that changes in the effective tax rate had a negligible impact on the volatility of the ROA compared to operational and financial drivers.

In summary, the erosion of ROA between 2022 and 2023 was a result of simultaneous declines in EBIT margin and the interest burden. While operational profitability recovered and stabilized by 2024, the long-term ROA was further pressured by a steady decline in asset turnover efficiency.


Disaggregation of Net Profit Margin

Thermo Fisher Scientific Inc., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Mar 28, 2026 = × ×
Dec 31, 2025 = × ×
Sep 27, 2025 = × ×
Jun 28, 2025 = × ×
Mar 29, 2025 = × ×
Dec 31, 2024 = × ×
Sep 28, 2024 = × ×
Jun 29, 2024 = × ×
Mar 30, 2024 = × ×
Dec 31, 2023 = × ×
Sep 30, 2023 = × ×
Jul 1, 2023 = × ×
Apr 1, 2023 = × ×
Dec 31, 2022 = × ×
Oct 1, 2022 = × ×
Jul 2, 2022 = × ×
Apr 2, 2022 = × ×

Based on: 10-Q (reporting date: 2026-03-28), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-27), 10-Q (reporting date: 2025-06-28), 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02).


The net profit margin exhibited a distinct U-shaped trajectory over the observed period, beginning at 18.49% in April 2022 and reaching a trough of 13.14% in July 2023. Following this decline, a steady recovery phase ensued, with the margin stabilizing between 15.02% and 15.23% throughout 2025 and early 2026.

Operating Efficiency (EBIT Margin)
The EBIT margin served as the primary driver of the fluctuations in overall profitability. A significant contraction is observed from April 2022 (22.24%) to July 2023 (16.29%), representing a decrease of approximately 595 basis points. Subsequently, operating margins recovered and remained remarkably consistent from March 2024 onward, plateauing within a narrow range of 19.38% to 19.56%.
Interest Burden
A sustained downward trend is evident in the interest burden ratio, which declined from 0.94 in mid-2022 to a low of 0.82 by March 2024. This suggests an increase in interest expenses relative to operating income, creating a persistent drag on the conversion of EBIT to net income. The ratio remained largely stagnant between 0.82 and 0.84 through March 2026.
Tax Burden
The tax burden ratio remained relatively stable, fluctuating between a minimum of 0.88 and a maximum of 0.95. A slight increase in the ratio was observed during 2023, indicating a lower effective tax rate during that period. From 2024 through 2026, the ratio normalized and stayed within the 0.91 to 0.94 range.

The disaggregation of the net profit margin reveals that while operational efficiency (EBIT margin) recovered from its 2023 lows to a stable baseline, the net profit margin did not return to its 2022 peaks. This discrepancy is primarily attributable to the deterioration of the interest burden, which shifted the baseline for non-operating expenses and capped the recovery of the bottom-line margin despite the stabilization of operating performance.